Sickle Cell Gene Therapy: Can We Afford a Cure? | Dr. Russ Weiner
BioTalk Unzipped15 Jan 2024

Sickle Cell Gene Therapy: Can We Afford a Cure? | Dr. Russ Weiner

In Episode 4, (Part 2 of our conversation with Dr. Russ Weiner - a top scientific leader at Takeda), we boldly explore the Cell and Gene Therapy Industry, questioning its trajectory and potential impact on insurance companies.

Shifting focus, we delve into a groundbreaking Sickle Cell Therapy breakthrough, discussing its triumphs, challenges, and the crucial aspect of affordability. Despite the hurdles faced by payers and insurance companies, we find inspiration in the thrill of witnessing healing.

Discover the role of AAPS in shaping the biotech future and efforts to engage students. Episode 4 also highlights Russ’ passions, including a heartfelt case study and insights into his AAPS Presidential platform. Explore surprising career moments, the transformative power of AI, and personal aspects of Russ’ life, from scuba diving to family.

The episode concludes with valuable advice on mentoring, self-worth, and navigating the intricacies of career development.

Join us on BioTalk Unzipped for a captivating journey where science meets stories, leaving you enlightened and inspired.

#biotechnology #AI

#careerdevelopment #cellgenetherapy #science #career

SEGMENTS

1:15 - Be Brutal to the Cell and Gene Therapy Industry - Where is CGT really going? Will it bankrupt insurance companies?

3:50 - Sickle Cell Therapy breakthrough, side effects, and affordability

4:22 - Difficulty for payers, insurance companies, but the thrill of people getting healed

8:20 - Role in AAPS. Bringing in students to AAPS.

10:16 - Russ’ #1 Passion and a Heartbreaking case study of a young woman.

11:06 - Russ’ #2 Passion and his AAPS Presidential platform and amazing science done outside the US

15:07 - What we need to do to help the world and realities we don’t often see

17:51 - What’s the most surprising thing in Russ’ career?

19:31 - AI changed everything

23:43 - Russ’ other passions: scuba diving and family

27:37 - Funny stories and knowing your worth

29:24 - Always mentoring and always find a mentor

31:09 - Who’s in charge of your career?

33:51 - The difference between career development and promotion

How to find our guest, Dr. Russ Weiner, Head Oncology and Cell Therapy Clinical Biomarker Sciences and Operations at Takeda:

https://www.linkedin.com/in/russellweiner/

Your BioTalk Unzipped Cohosts:

Gregory Austin, Business Development Manager at ProPharma Group

https://www.linkedin.com/in/gregoryaustin1/

Dr. Chad Briscoe, Executive Vice President of Global Bioanalytical Services at Celerion

https://www.linkedin.com/in/chadbriscoe/

Image credits: Image by Tumisu from Pixabay Giphy: The Chemical Brothers; PBS Digital Studios; http://www.gizmodo.com.au/2015/07/did-an-australian-university-just-say-wi-fi-gives-you-and-your-kids-cancer/; http://dynamicoceans.tumblr.com/post/99418047836/manta-ray-glittering-in-the-sunlight-despite Photo by Andres Siimon on Unsplash Tenor AAPS Cardiac cell beating courtesy of IGI Deputy Director Bruce Conklin Liquid Diving Adventures, https://www.liquiddivingadventures.com/blog/post/2020/11/27/socorro-islands-mexico-only-by-liveaboard

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(47)

Is AI Changing Scientists? The Future of Pharma with Dr. Rob Dodge

Is AI Changing Scientists? The Future of Pharma with Dr. Rob Dodge

Rob Dodge says AI has made him an expert Python programmer, even though he never took a class in it. But does having new capabilities change what it means to be a scientist?Dr. Chad Briscoe sits down ...

2 Okt 35min

Do Clinical Trials Take Too Much Blood? Patient-Centric Sampling with Joleen White

Do Clinical Trials Take Too Much Blood? Patient-Centric Sampling with Joleen White

Clinical trials often collect far more blood than an assay actually needs. Dr. Joleen White asks a more disciplined question: What information is required to make a sound decision, and how little samp...

11 Sep 48min

Why Gene Therapy Is Still So Hard to Manufacture at Scale | Phillip Ramsey

Why Gene Therapy Is Still So Hard to Manufacture at Scale | Phillip Ramsey

Why is gene therapy still so difficult to manufacture at scale after decades of progress?Phillip Ramsey, Chief Technical Officer at Sangamo Therapeutics, joins BioTalk Unzipped for a candid conversati...

8 Aug 11min

Her Daughter’s Brain Tumor Turned Her Into a Biotech Founder | Tracy Ryan

Her Daughter’s Brain Tumor Turned Her Into a Biotech Founder | Tracy Ryan

A mother’s search for answers to her daughter’s relentless brain tumor led her into natural killer cell biology, cancer immunotherapy, and biotech entrepreneurship.Sponsored by Leucentra, https://leuc...

20 Jul 1h 4min

The Future of Oncology Drug Development | Dr. Lakshmi Amaravadi

The Future of Oncology Drug Development | Dr. Lakshmi Amaravadi

Oncology drug development is becoming more complex, and bioanalysis can no longer be treated as simple drug measurement.Sponsored by Leucentra, https://leucentra.com/Inspired by science, empowered by ...

11 Jun 29min

Active Machine Learning for Drug Discovery & Nanomedicine with Dr. Daniel Reker

Active Machine Learning for Drug Discovery & Nanomedicine with Dr. Daniel Reker

Can artificial intelligence help make cancer therapies safer, more targeted, and more effective?In this episode of BioTalk Unzipped, Gregory Austin sits down with Dr. Daniel Reker, Assistant Professor...

25 Apr 50min

Why Haven’t We Cured Cancer Yet? | Dr. Bob Liu Explains

Why Haven’t We Cured Cancer Yet? | Dr. Bob Liu Explains

Why haven’t we cured cancer yet? A Genentech scientist explains the real reason.In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Bob Liu, Senior Principal Sci...

19 Mar 1h

The Intersection of Biotech, Patent Law, and AI with Dr. Kate Neville, IP Attorney

The Intersection of Biotech, Patent Law, and AI with Dr. Kate Neville, IP Attorney

Recorded October 31, 2025In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Kate Neville, immunologist turned seasoned biotech patent attorney at Marshall, Gers...

16 Feb 52min

Populært innen Business og økonomi

stopp-verden
dine-penger-pengeradet
e24-podden
rss-penger-polser-og-politikk
rss-borsmorgen-okonominyhetene
rss-skravla-gar
rss-pa-konto
finansredaksjonen
livet-pa-veien-med-jan-erik-larssen
lederpodden
pengepodden-2
pengesnakk
utbytte
liberal-halvtime
okonomiamatorene
rss-orjasater
morgenkaffen-med-finansavisen
tid-er-penger-en-podcast-med-peter-warren
rss-markedspuls-2
stormkast-med-valebrokk-stordalen